Replies to post #316 on Relypsa Inc (RLYP)

[ciciagt]

Relypsa (NASDAQ:RLYP) is up 3% after hours on increased volume in response to the release of the June total of new patients who started Veltassa (patiromer) with a free starter supply. The number for last month was 1,531, up 10.5% from May and up almost 26% from April.Outpatient prescriptions covered and filled were 1,723 for June, up up 40% since May and up almost 86% since April. Hospital/institution units sold rebounded from the dip in May to 392, up over 41% sequentially.
http://seekingalpha.com/news/3192621-new-patient-ramp-relypsas-veltassa-shows-consistent-growth-past-three-months-shares-3-percent

[BigGreen101]

Yes indeed. Payed scripts are starting to get some real traction. We might even see a pop next month due to Medicare approval deadline for Veltassa has passed late last month. Cheers!

[girlfriend]